| Literature DB >> 23497259 |
Mireia Olivella1, Gianluigi Caltabiano, Arnau Cordomí.
Abstract
BACKGROUND: The CWxP motif of transmembrane helix 6 (x: any residue) is highly conserved in class A GPCRs. Within this motif, W6.48 is a big star in the theory of the global "toggle switch" because of its key role in the activation mechanism of GPCRs upon ligand binding. With all footlights focused on W6.48, the reason why the preceding residue, C6.47, is largely conserved is still unknown. The present study is aimed to fill up this lack of knowledge by characterizing the role of C6.47 of the CWxP motif.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23497259 PMCID: PMC3610275 DOI: 10.1186/1472-6807-13-3
Source DB: PubMed Journal: BMC Struct Biol ISSN: 1472-6807
The 6.47-7.45 interaction in the analyzed crystal structures
| | |||||||
|---|---|---|---|---|---|---|---|
| β2-adrenergic | β2ARINV | 2RH1 [ | 2.4 | C6.47-N7.45 | CO | 3.8 | 84.5 |
| β2ARAGO | 3SN6 [ | 3.2 | CO | 4.4 | 81.2 | ||
| β1-adrenergic (turkey) | β1ARINV | 2VT4 [ | 2.7 | C6.47-N7.45 | CO | 3.7 | 79.3 |
| β1ARAGO | 2Y02 [ | 2.6 | CO | 3.9 | 85.3 | ||
| Dopamine D3 | D3RINV | 3PBL [ | 2.9 | C6.47-N7.45 | CO | 3.8 | 81.6 |
| Histamine H1 | H1RINV | 3RZE [ | 3.1 | C6.47-N7.45 | CO | 4.2 | 80.9 |
| Adenosine A2A | A2ARINV | 4EIY [ | 1.8 | C6.47-N7.45 | NH2 | 3.9 | 84.5 |
| | A2ARAGO | 2YDV [ | 2.6 | | CO | 4.3 | 74.4 |
| κ opioid | κORINV | 4DJH [ | 2.9 | C6.47-N7.45 | CO | 4.1 | 81.2 |
| μ opioid (mouse) | μORINV | 4DKL [ | 2.8 | C6.47-N7.45 | CO | 3.6 | 87.5 |
| δ opioid (mouse) | δORINV | 4EJ4 [ | 3.4 | C6.47-N7.45 | NH2 | 3.8 | 89.8 |
| N/OFQ Opioid | N/OFQINV | 4EA3 [ | 3.0 | C6.47-N7.45 | NH2 | 4.2 | 85.6 |
| Sphingosine 1-phosph. 1 | S1PR1INV | 3V2Y [ | 2.8 | C6.47-N7.45 | NH2 | 3.4 | 81.1 |
| CXCR4 chemokine | CXCR4INV | 3ODU [ | 2.5 | C6.47-H7.45 | - | - | - |
| M2 musc. ach. | M2RINV | 3UON [ | 3.0 | T6.47-N7.45 | NH2 | 3.2 | 120.2 |
| M3 musc. ach. (rat) | M3RINV | 4DAJ [ | 3.4 | T6.47-N7.45 | NH2 | 4 | 140.7 |
| Rhodopsin (bovine) | bRhoINV | 1GZM [ | 2.7 | C6.47-T7.44 | - | 3.7 | 101.8 |
| bRhoAGO | 3PQR [ | 2.9 | - | 8.8 | - | ||
| Rhodopsin (squid) | sRhoINV | 2Z73 [ | 2.5 | Q6.43-S7.54 | - | 2.4 | 111.2 |
(Left) Crystal structures used within the manuscript (INV: inverse agonist or antagonist; AGO: agonist); Protein Data Bank Identification Code and Resolution; receptor structures are human unless stated. (Right) Characterization of the TM6-TM7 hydrogen bond: pair involved, N7.45 rotamer (CO/NH2 indicates the closer group to C6.47 as in their crystal structure), donor(D)-acceptor(A) distance and Cβ-donor(D)···acceptor(A) angle.
Residues present at positions 6.47 and 7.42-7.48
| β2-adrenergic | G | Y | V | S | G | F | ||
| β1-adrenergic (turkey) | G | Y | V | S | A | F | ||
| Dopamine D3 | G | Y | V | N | S | A | L | |
| Histamine H1 | G | Y | I | S | T | L | ||
| Adenosine A2A | S | H | S | C | L | |||
| κ opioid | G | Y | T | S | S | L | ||
| μ opioid (mouse) | G | Y | T | S | C | L | ||
| δ opioid (mouse) | G | Y | A | S | S | L | ||
| N/OFQ Opioid | G | Y | V | N | S | C | L | |
| Sphingosine 1-phosph. 1 | A | V | L | S | G | T | ||
| CXCR4 chemokine | A | F | F | C | A | L | ||
| M2 musc. ach. | C | Y | I | S | T | I | ||
| M3 musc. ach. (rat) | C | Y | I | S | T | V | ||
| Rhodopsin (bovine) | A | K | Sg- | A | V | Y | ||
| Rhodopsin (squid) | A | K | A | A | I | H | ||
Rotamer of C, S and T (g+/-: gauche+/-, t: trans) is indicated when relevant; residues involved in TM6-TM7 hydrogen bonds are displayed in bold.
Figure 1Analysis of TM6 irregularities computed from MD simulations of polyalanine peptides containing the CAAP, SAAP, TAAP motifs in the gauche-, gauche + and trans conformers. Difference between average Φ (A) and Ψ (B) dihedral angles, unit bend (C) and unit twist (D) profiles. CtAAP and Cg+AAP are the unique peptide conformations that present very similar helical geometrical parameters to AAAP. Sg+AAP peptide present certain distortion relative to AAAP peptide and Cg-AAP, Sg-AAP, StAAP, Tg+AAP, Tg-AAP, TtAAP present the most distorted helical geometrical parameters relative to AAAP peptide. Bend and twist angles assigned at position i corresponds to the value computed for (i-3, i) and (i, i + 3) and for (i-3, i), respectively.
Population of C/S/T rotamers in transmembrane helices from crystal structures
| Cysteine | 0 | 71 | 29 |
| Threonine | 15 | 84 | 1 |
| Serine | 20 | 52 | 28 |
Data arranged from reference [47].
Figure 2The TM6-TM7 interface in βARstructure. A) Hydrophobic residues (white surface) and free carbonyl groups (red) surrounding C6.47 (grey surface). B-D) Hydrogen bond network at the TM6 and TM7 interface (indicated by dotted lines). B) In β2ARINV (left) C6.47 forms a hydrogen bond with N7.45 and eventually with the backbone of 6.43; in β2ARAGO (right) the hydrogen bond between 6.47 and N7.45 is broken and C6.47 interacts only with the backbone of 6.43. C) sRHOINV features Q6.43 bridging S6.47 and S7.45. D) In RHOINV (left) C6.47 is interacting with T7.44 g+; in RHOAGO the hydrogen bond between Cys 6.47 and T7.44 has broken. Color code is as follows: TM6 (blue), TM7 (pale red).
Figure 3Hydrogen bond network associated to C6.47 in both inverse-agonist (left) and agonist (right) bound structures of βAR (A) and bRho (B). Panel A: C6.47 hydrogen bonds N7.45 which retains N7.49, avoiding interaction of the latter with D2.50 (left). Breaking of C6.47-N7.45 interaction releases (right) N7.49 permitting its interaction with D2.50. Panel B: the release of both C6.47-T7.44 and Y7.48-N7.49 hydrogen bonds (left), permits N7.49 to form a hydrogen bond with D2.50. Helices are colored as follows: TM1:white, TM2:gold, TM3:red, TM6:blue and TM7:pale-red. The remaining helices have been omitted for better clarity. Relevant side-chains are shown as sticks (cyan) and hydrogen bonds are indicated by dashed lines. A crystallographic water molecule is shown as spheres.